Genetic variants of TYR and MC1R in biosynthesis of melanin and skin pigmentation are correlated with JDM and cSLE with photosensitive rash 2260556

D Danlei Zhou (Abigail Wexner Research Institute, Nationwide Children’s Hospital) R Rabhhed Abdul-Aziz (University at Buffalo Jacobs School of Medicine and Biomedical Sciences) S Samantha Coss (Abigail Wexner Research Institute, Nationwide Children’s Hospital) K Kyla Driest (Division of Rheumatology, Nationwide Children’s Hospital and Department of Pediatrics) S Shoghik Akoghlanian (Division of Rheumatology, Nationwide Children’s Hospital and Department of Pediatrics) S Stacy Ardoin (Division of Rheumatology, Nationwide Children’s Hospital and Department of Pediatrics) C Chack-Yung Yu (Abigail Wexner Research Institute, Nationwide Children’s Hospital)

Abstract

Abstract Introduction Juvenile dermatomyositis (JDM) and Systemic Lupus Erythematosus (SLE) are systemic autoimmune diseases characterized by production of autoantibodies against cellular and nuclear antigens and complement-mediated tissue injuries. Common clinical presentations of JDM and cSLE include photosensitive rashes on the skin, although the patterns of rash are different. We seek to determine the genetic features of these two diseases. Methods Data from whole exomes sequencing of 51 patients with JDM and 43 patients with cSLE revealed two nonsynonymous variants, S192Y and R402Q in the tyrosinase gene (TYR), which encodes a key enzyme in melanin biosynthesis and skin pigmentation. We developed restriction fragment length polymorphisms (RFLP) of PCR amplified genomic DNA fragments using Hpy188I digest or HpyAV digest to identify the S192Y and R402Q variations, respectively. Results The S192Y variant has significantly higher frequency in JDM than controls (41% vs 25%, p = 0.0003), while R402Q has higher frequency in cSLE than controls (32.6% vs 17.6%, p = 0.0006). Intriguingly, another protein engaged in the melanin synthesis pathway, melanocortin-1 receptor MC1R, has non-synonymous variant for R160W. FauI RFLP was developed to detect this R160W polymorphism in MC1R. Close to 21.6% JDM patients have a homozygous or heterozygous variant of R160W in MC1R (p = 0.001). Conclusion Overall, 88% of patients with JDM or cSLE have a variant in S192Y or R402Q of TYR, or R160W of MC1R. Further experiments are in progress to manipulate the expression and functional activities of TYR and MC1R. Funding Source Cure JM Topic Categories Basic Autoimmunity (BA)

Article Details

Volume / Issue Vol. 215, Issue Supplement_1
Published August 01, 2026
ISSN 0022-1767
Publisher American Association of Immunologists

Authors (7)

D

Danlei Zhou

Abigail Wexner Research Institute, Nationwide Children’s Hospital

R

Rabhhed Abdul-Aziz

University at Buffalo Jacobs School of Medicine and Biomedical Sciences

S

Samantha Coss

Abigail Wexner Research Institute, Nationwide Children’s Hospital

K

Kyla Driest

Division of Rheumatology, Nationwide Children’s Hospital and Department of Pediatrics

S

Shoghik Akoghlanian

Division of Rheumatology, Nationwide Children’s Hospital and Department of Pediatrics

S

Stacy Ardoin

Division of Rheumatology, Nationwide Children’s Hospital and Department of Pediatrics

C

Chack-Yung Yu

Abigail Wexner Research Institute, Nationwide Children’s Hospital